CB4211 (The New MOTS-C)

CB4211 (The New MOTS-C) represents the next evolution in mitochondrial optimization and metabolic peptide therapy. Derived from the MOTS-C mitochondrial peptide, CB4211 is an enhanced analog engineered for greater bioavailability and stability, offering powerful effects on energy metabolism, insulin sensitivity, and cellular resilience.

This cutting-edge peptide targets metabolic dysfunction at the mitochondrial level, helping to rebalance cellular energy systems and reduce oxidative stress — foundational for longevity, body composition improvement, and anti-aging performance.

Mechanism of Action:
CB4211 works by activating AMPK pathways and regulating mitochondrial gene expression, optimizing fat utilization, glucose metabolism, and cellular energy output. It promotes metabolic flexibility and helps the body respond better to oxidative and inflammatory stressors associated with aging.

Key Benefits:

• Enhances cellular energy and mitochondrial efficiency

• Promotes fat metabolism and lean body composition

• Improves insulin sensitivity and metabolic balance

• Supports anti-aging and longevity pathways

• Reduces oxidative stress and inflammation

Clinical Applications:

• Metabolic and mitochondrial optimization

• Weight management and energy enhancement

• Anti-aging and longevity protocols

• Insulin resistance and cellular repair support

✅ Format: Injectable peptide 
✅ Storage: Refrigerate for potency and stability.
✅ Use: Administer subcutaneously as directed by your provider.

⚠️ Note: For professional use only. Use under medical supervision.